Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Mini-dose Dexmedetomidine-Esketamine Infusion on Sleep Quality in Older Patients Undergoing Knee or Hip Replacement Surgery
NCT05950646Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- Jan 2024
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine, esketamine in sleep disorders, sponsored by Peking University First Hospital. Started Jan 2024; status: completed.
02
Drugs
dexmedetomidineesketamine
03
Conditions
sleep disorders
Beyond the preview
Go deeper on NCT05950646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05950646.